Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens
1999662 citationsPer Fauchald, Svein Simonsen et al.profile →
Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial
2003660 citationsHallvard Holdaas, Bengt Fellström et al.profile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of Per Fauchald's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Fauchald with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Fauchald more than expected).
This network shows the impact of papers produced by Per Fauchald. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Fauchald. The network helps show where Per Fauchald may publish in the future.
Co-authorship network of co-authors of Per Fauchald
This figure shows the co-authorship network connecting the top 25 collaborators of Per Fauchald.
A scholar is included among the top collaborators of Per Fauchald based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Per Fauchald. Per Fauchald is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Moe, Børge, Françoise Amélineau, Morten Ekker, et al.. (2021). An automated procedure (v2.0) to obtain positions from light-level geolocators in large-scale tracking of seabirds. A method description for the SEATRACK project. Duo Research Archive (University of Oslo).1 indexed citations
Fauchald, Per, Arnaud Tarroux, Sébastien Descamps, et al.. (2019). Arctic-breeding seabirds’ hotspots in space and time - A methodological framework for year-round modelling of environmental niche and abundance using light-logger data. Duo Research Archive (University of Oslo).2 indexed citations
8.
Fauchald, Per, Per Arneberg, Jørgen Berge, et al.. (2014). An assessment of MOSJ: the state of the marine environment around Svalbard and Jan Mayen. Duo Research Archive (University of Oslo).1 indexed citations
9.
Tveraa, Torkild, Manuel Ballesteros, Bård‐Jørgen Bårdsen, et al.. (2013). Beregning av produksjon og tap i reindriften. Duo Research Archive (University of Oslo).2 indexed citations
10.
Fauchald, Per. (2011). Sjøfugl i åpent hav. Utbredelsen av sjøfugl i norske og tilgrensende havområder. Duo Research Archive (University of Oslo).4 indexed citations
11.
Forsgren, Elisabet, Signe Christensen‐Dalsgaard, Per Fauchald, Johanna Järnegren, & Tor F. Næsje. (2009). Norwegian marine ecosystems – are northern ones more vulnerable to pollution from oil than southern ones?. Duo Research Archive (University of Oslo).4 indexed citations
12.
Fauchald, Per, et al.. (2005). Simulering av fordelingsmønsteret til sjøfugl som en komponent i MIRA. BIBSYS Brage (BIBSYS (Norway)).1 indexed citations
13.
Hartmann, Anders, Trond Jenssen, Karsten Midtvedt, et al.. (2002). Protein-kreatinin-ratio – en enkel metode for vurdering av proteinuri i klinisk praksis. Tidsskrift for Den Norske Laegeforening.1 indexed citations
14.
Holdaas, Hallvard, Bengt Fellström, Ingar Holme, et al.. (2001). Effects of fluvastatin on cardiac events in renal transplant recipients. Journal of Cardiovascular Risk. 63–71.1 indexed citations
Kovarik, John M., E Rawlings, P. Sweny, et al.. (1996). Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation.. PubMed. 28(2). 913–4.31 indexed citations
Fauchald, Per, Hallvard Holdaas, D Albrechtsen, & A Flatmark. (1989). The use of elderly living donors. Kidney International. 35(1). 513.3 indexed citations
19.
Fauchald, Per, et al.. (1978). [Treatment of high blood pressure with prazosin (Peripress). An open study by 123 general physicians and 24 specialists in internal medicine].. PubMed. 98(30). 1494–9.1 indexed citations
20.
Fauchald, Per, et al.. (1972). [Focal glomerulonephritis--a term to be avoided].. PubMed. 92(7). 494–6.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.